Challenges of Investigator-initiated Clinical Trials to Support the New Drug Development
A large number of investigator-initiated clinical trials (IIT) were conducted in China, some of them should play an important supporting role in new drug development. Due to the large number, small scale and uneven quality of IIT in China, especially a big gap between the IIT and industry-sponsored...
Main Authors: | Hua BAI, Shuyang ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2022-07-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.31 |
Similar Items
-
Investigator Initiated Trials: modern trends
by: A. G. Torubarova, et al.
Published: (2019-01-01) -
Protocol-writing support conferences for investigator-initiated clinical trials
by: Goto M, et al.
Published: (2016-04-01) -
Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated Trials
by: Dinesh Pal Mudaranthakam, et al.
Published: (2020-06-01) -
Investigation of Procedural Decisions at the Beginning of Pre-Trial Investigation
by: Yа. A. Burlaka
Published: (2020-12-01) -
The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center
by: Weijing Sun, et al.
Published: (2023-11-01)